HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitochondria are primary targets in apoptosis induced by the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I) in melanoma cell lines.

Abstract
Based on previous evidence indicating a selective cytotoxic activity of the mixed phosphine gold complex chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I) for melanoma cells, we investigated the cellular bases of its antiproliferative effect in a panel of human melanoma cell lines (JR8, SK-Mel-5, Mel-501, 2/60, 2/21 and GRIG). The drug consistently induced a dose-dependent inhibition of cell growth, with IC50 values ranging from 0.8 to 2.3 microM and, when tested under the same experimental conditions, its cytotoxic activity was higher than (from 2- to 5-fold) or comparable to that of cisplatin as a function of cell lines. The ability of the gold complex to activate programmed cell death was assessed in JR8 and 2/60 cells, and a dose-dependent increase in cells with an apoptotic nuclear morphology was observed in both cell lines (up to 40 and 66% of the overall cell population, for JR8 and 2/60 cell lines, respectively). Such an apoptotic response was mediated by a dose-dependent loss of mitochondrial membrane potential, cytochrome c and Smac/DIABLO release from mitochondria into cytosol and enhanced caspase-9 and caspase-3 catalytic activity. A reduced or completely abrogated expression of the anti-apoptotic proteins c-IAP1, XIAP and survivin in drug-treated cells was also observed. Overall, results from the study indicate that chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I) markedly inhibits melanoma cell growth by inducing mitochondria-mediated apoptosis and suggest it as a good candidate for additional evaluation as an anticancer agent against melanoma.
AuthorsFrancesco Caruso, Raffaella Villa, Miriam Rossi, Claudio Pettinari, Francesco Paduano, Marzia Pennati, Maria Grazia Daidone, Nadia Zaffaroni
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 73 Issue 6 Pg. 773-81 (Mar 15 2007) ISSN: 0006-2952 [Print] England
PMID17188248 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Organogold Compounds
  • chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I)
  • Caspase 3
  • Caspase 9
Topics
  • Antineoplastic Agents (pharmacology)
  • Caspase 3 (metabolism)
  • Caspase 9 (metabolism)
  • Cell Line, Tumor
  • Dose-Response Relationship, Drug
  • Humans
  • Melanoma (drug therapy, pathology)
  • Mitochondria (drug effects)
  • Organogold Compounds (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: